Evaluation of attenuation correction methodology in the allegro PET system
- 18 October 2004
- journal article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nuclear Science
- Vol. 51 (5), 2688-2692
- https://doi.org/10.1109/TNS.2004.835741
Abstract
This paper describes the evaluation of an attenuation correction methodology implemented in the Philips Allegro PET device. This system uses a /sup 137/Cs point source (single photon emitter at 662 keV) to perform postinjection transmission scans for clinical whole body FDG investigations. The aims of our study were: 1) to assess the use of a single scaling factor in the conversion of the attenuation coefficients from the acquired energy of 662 keV to the emission energy of 511 keV, throughout a range of different density materials; 2) to assess the effects of scatter in the accuracy of the measured attenuation maps; and 3) to evaluate the accuracy of postinjection transmission scanning. First, measurements of attenuation coefficients were carried out for different density materials at 662 keV and 511 keV using a narrow beam geometry laboratory setup. The same materials were subsequently scanned using the transmission setup of the PET system. In addition, emission and transmission datasets of the NEMA NU2 phantom, including the three inserts (water, air, and teflon), were obtained using the Allegro PET system. Transmission scans of the NEMA phantom were carried out in the presence and absence of activity in order to assess the accuracy of the postinjection transmission acquisitions. Finally, the transmission maps of patients studies were analyzed. The attenuation coefficients measured with the laboratory benchmark are in good agreement with tabulated data available in the literature. A linear relationship between the attenuation coefficients at 662 and 511 keV, through the range of material densities examined was observed for both the benchmark and the scanner transmission measurements. No differences were observed between the attenuation coefficients in the NEMA phantom in the presence and absence of emission activity. Finally, both phantom and patient studies reveal a bias in areas of low densities, such as in water and lung, most probably as a result of using a single scaling factor for all attenuation coefficients in order to correct for the effects of scattered events in the measured transmission maps.Keywords
This publication has 6 references indexed in Scilit:
- Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methodsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Clinical role of positron emission tomography in oncologyThe Lancet Oncology, 2001
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Attenuation correction for a combined 3D PET/CT scannerMedical Physics, 1998
- A comparison of segmentation and emission subtraction for singles transmission in PETIEEE Transactions on Nuclear Science, 1998